Search results
Volta Medical Presents Results From First Transatlantic Randomized Controlled Trial Comparing...
NewMediaWire via Yahoo Finance· 22 hours agoTAILORED-AF trial findings demonstrated superiority in freedom from atrial fibrillation (AF) with or...
Ozempic, Wegovy to be tested as alcohol-related liver disease therapies
Becker’s Hospital Review· 6 days agoNovo Nordisk is investigating the potential of Ozempic, Wegovy's active ingredient and two other drug candidates as treatments for alcohol-related liver disease. The phase 2 trial will see how ...
Breast Cancer Risk After Bariatric Surgery and Influence of Insulin Levels
Journal of the American Medical Association· 6 days agoThis nonrandomized controlled trial evaluates the association between bariatric surgery and breast cancer incidence and whether this association varies by baseline insulin level.
Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose...
WJTV Jackson· 7 days agoThe primary objective of this phase 1 study will be to determine the recommended phase 2 dose (RP2D) for Triapine® in combination with temozolomide (TMZ).
Spago Nanomedical Provides an Update on Tumorad-01
Digital Journal· 1 day agoMore information about the Tumorad-01 study is available at https://clinicaltrials.gov/study/NCT06184035 For further information, please contact Mats Hansen, CEO Spago Nanomedical ...
NIH Reports Benign Nail Condition Linked to Rare Syndrome that Greatly Increases Cancer Risk
Sierra Sun Times· 3 days agoNIH researchers suggest conducting nail evaluation of affected patients and at-risk family members....
BioCorRx Reports Business Update for the First Quarter of 2024
NewMediaWire via Yahoo Finance· 5 days agoANAHEIM, CA - (NewMediaWire) - May 16, 2024 - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 7 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
LiveSpo Pharma Emerges as Vietnam's Pioneer at Vitafoods Europe 2024
Digital Journal· 4 days agoMedia OutReach Newswire - 17 May 2024 - LiveSpo Pharma is the first Vietnamese entity to report on two clinical studies at the world's leading nutrition exhibition, Vitafoods Europe 2024, held ...
HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery
WTNH-TV New Haven· 1 day agoUp to 18% of patients undergoing ACL reconstruction experience graft failure and require revision surgery, which is known to increase the risk of developing post-traumatic osteoarthritis (PTOA ...
